Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Change in Account Payables: 2017-2024

Historic Change in Account Payables for IDEAYA Biosciences (IDYA) over the last 8 years, with Dec 2024 value amounting to $8.3 million.

  • IDEAYA Biosciences' Change in Account Payables rose 130.24% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year decrease of 7.35%. This contributed to the annual value of $8.3 million for FY2024, which is 214.23% up from last year.
  • IDEAYA Biosciences' Change in Account Payables amounted to $8.3 million in FY2024, which was up 214.23% from $2.6 million recorded in FY2023.
  • In the past 5 years, IDEAYA Biosciences' Change in Account Payables ranged from a high of $8.3 million in FY2024 and a low of $225,000 during FY2020.
  • In the last 3 years, IDEAYA Biosciences' Change in Account Payables had a median value of $2.6 million in 2023 and averaged $4.3 million.
  • Data for IDEAYA Biosciences' Change in Account Payables shows a peak YoY skyrocketed of 418.22% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows IDEAYA Biosciences' Change in Account Payables stood at $225,000 in 2020, then spiked by 418.22% to $1.2 million in 2021, then skyrocketed by 59.86% to $1.9 million in 2022, then spiked by 41.36% to $2.6 million in 2023, then soared by 214.23% to $8.3 million in 2024.